Inside informationEnglish
NFL Biosciences strengthens its scientific committee with world-class experts to support the Phase 3 development of NFL-101, its first-in-class therapy for tobacco addiction
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- NFL Biosciences
- Filed
- 12/05/2025, 08:29
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 078492_20250512